Wafra Inc. Illumina, Inc. Transaction History

Wafra Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 11, 2021	SELL	$292.7 - $370.96 $14.4 Million - $18.2 Million	-49,138 Closed	0 $0
Q3 2020 Nov 12, 2020	BUY	$268.51 - $400.74 $4.07 Million - $6.08 Million	15,173 Added 44.67%	49,138 $15.2 Million
Q1 2020 May 07, 2020	SELL	$209.2 - $335.53 $4.29 Million - $6.88 Million	-20,494 Reduced 37.63%	33,965 $9.28 Million
Q4 2019 Feb 05, 2020	BUY	$288.29 - $335.49 $5.98 Million - $6.96 Million	20,747 Added 61.54%	54,459 $18.1 Million
Q2 2018 Aug 09, 2018	SELL	$228.17 - $292.07 $4.82 Million - $6.17 Million	-21,132 Reduced 38.53%	33,712 $9.42 Million
Q1 2018 May 15, 2018	BUY	$209.54 - $253.91 $146,887 - $177,990	701 Added 1.29%	54,844 $13 Million
Q4 2017 Feb 14, 2018	BUY	$202.23 - $230.03 $5.26 Million - $5.98 Million	26,011 Added 92.46%	54,143 $11.8 Million
Q3 2017 Nov 14, 2017	BUY	$172.3 - $213.93 $4.85 Million - $6.02 Million	28,132	28,132 $5.6 Million

904

137M

1.22M

1.43M

Ticker ILMN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 157,300,000
Market Cap $21.5B
Description
Illumina, Inc. provides sequencing and array-based solutions for genetic and genomic analysis. Its products and services serve customers in a range of markets enabling the adoption of genomic solutions in research and clinical settings for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments....

Get notified when there are updates to the investment portfolio of Wafra Inc., based on Form 13F filings with the SEC.

Stay updated on Wafra Inc. with notifications on news.